title: Evaluation and Management of Adolescents with Abnormal Uterine Bleeding.
abstract: The International Federation of Gynecology and Obstetrics and the American Congress of Obstetricians and Gynecologists support the use of new terminology for abnormal uterine bleeding (AUB) to consistently categorize AUB by etiology. The term AUB can be further classified as AUB/heavy menstrual bleeding (HMB) (replacing the term "menorrhagia") or AUB/intermenstrual bleeding (replacing the term "metrorrhagia"). Although many cases of AUB in adolescent women are attributable to immaturity of the hypothalamic-pituitary-ovarian axis, underlying bleeding disorders should be considered in women with AUB/HMB. This article reviews the new terminology for AUB, discusses important relevant features of history and examination, presents the laboratory evaluation of HMB, and describes hormonal (oral contraceptive pills, progestin-only methods, long-acting reversible contraceptives including intrauterine systems), hematologic (tranexamic acid and desmopressin), and surgical management options for AUB/HMB.
authors.forename: Tanya L Kowalczyk
authors.initials: TL
authors.lastname: Mullins
authors.forename: Rachel J
authors.initials: RJ
authors.lastname: Miller
authors.forename: Eric S
authors.initials: ES
authors.lastname: Mullins
mesh_terms: D000293:Adolescent; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use; D019468:Disease Management; D005260:Female; D006801:Humans; D014592:Uterine Hemorrhage / Q000175:diagnosis* / Q000601:surgery / Q000628:therapy*
chemical_list: D000933:Antifibrinolytic Agents; D003278:Contraceptives, Oral, Hormonal